{"disease":{"id":"atrophy-geographic","name":"atrophy geographic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03845582","title":"Phase 2/3 Study of ALK-001 in Geographic Atrophy","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Alkeus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT01342926","title":"Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02033668","title":"Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}